U.S. Pharma Stock News

Axsome Therapeutics (AXSM) has drawn attention after recent trading, with the stock closing at US$253.77. Investors are weighing this move against the company’s central nervous system focused drug portfolio and ongoing clinical programs. See our latest analysis for Axsome Therapeutics. The recent 3.02% 1 day share price return, along with a 62.59% 90 day share price return and 138.84% 1 year total shareholder return, points to strong momentum as investors reassess Axsome Therapeutics’ CNS...

If you are wondering whether Hecla Mining's current share price offers value or is running ahead of itself, the next sections break down what the numbers actually say about the stock. The share price closed at US$14.99, with the stock down 10.9% over the past week and 27.1% over the past month, although the 1-year return of 150.5% and 3-year return of 190.3% still stand out. These swings in performance have kept Hecla Mining on many investors' watchlists, as the stock has moved sharply both...

Metropolitan Bank Holding (MCB) has recently drawn investor attention after its stock closed at $96.18, with performance over the past month and past 3 months prompting closer scrutiny of this regional bank. See our latest analysis for Metropolitan Bank Holding. The recent 2.44% 1 day share price return, alongside a 24.96% year to date share price return and a 47.12% 1 year total shareholder return, points to momentum that investors are weighing against the current valuation and risk...

In recent days, GPGI completed its conversion to a Nevada corporation, saw all 2026 annual meeting proposals approved, and CompoSecure appointed Ian Snadden as Chief Commercial Officer, International to lead global sales efforts. Taken together, the governance shift, auditor appointment and new international commercial leadership highlight a corporate focus on legal flexibility and overseas expansion at a time of operational and market challenges. Next, we’ll examine how GPGI’s move to...

Merck Animal Health has agreed to acquire TARGAN, a poultry biodevice company focused on high speed gender identification and vaccine delivery. The company is also partnering with the Hashgraph Group to integrate Hedera powered digital product passports with its M-Trust authentication platform. Both moves expand Merck's reach into animal health automation and supply chain traceability tied to new EU transparency rules. For investors following Merck (NYSE:MRK), this news sits alongside a...

Wondering whether AMN Healthcare Services at around US$30.79 is offering value right now or just catching your eye after a big move. The stock is up 0.6% over the last week and 4.5% over the past month, with a 103.6% return year to date and a 42.4% gain over the last year, even though the share price has fallen 71.6% over three years and 67.7% over five years. Recent coverage has focused on how AMN Healthcare Services fits into investor interest around healthcare staffing and workforce...

Plug Power (NasdaqCM:PLUG) reports sharply improved margins and tighter cost controls, highlighting early signs of an operational turnaround. The company outlines progress on its Project Quantum Leap initiative, targeting leaner operations and better capital discipline. New CEO José Luis Crespo accelerates a shift toward vertical integration, including more in house hydrogen production capacity. Management frames these changes as a structural move toward profitability in Plug Power's...

Renasant (RNST) has drawn fresh attention after recent share price moves, with the stock last closing at $42.26. Investors are weighing this performance against the bank's mix of community banking and wealth management operations. See our latest analysis for Renasant. Recent trading has come on the back of a firm run in the share price, with a 30 day share price return of 6.72% feeding into a 19.48% year to date gain and a 20.93% 1 year total shareholder return. This suggests that momentum...

Legend Biotech recently reported early Phase 1 data for LB2501, an investigational in vivo CD19/CD20 dual-targeting CAR-T therapy in relapsed/refractory B-cell non-Hodgkin lymphoma, showing high response rates, dose-dependent in vivo CAR-T expansion, and a manageable safety profile without lymphodepleting chemotherapy. The ability of LB2501 to generate CAR-T cells directly inside patients from a single off-the-shelf infusion could materially simplify treatment logistics compared with...

This article examines whether Equinix, at around US$1,043 per share, is offering good value or embedding high future expectations, by breaking down what the current price might be implying. Over the past week the stock is down 4.2% and over the past month it is down 3.5%. Year to date it is up 36.5% and over the last year it has returned 19.0%, which naturally raises questions about how much of that performance is already reflected in the price. Over the last three and five years, Equinix...

Etsy (NYSE:ETSY) and its subsidiary Depop have released a joint whitepaper calling for regulatory reforms to support the circular economy and secondhand market. The paper urges policymakers to update rules, reduce administrative and tax frictions, and provide more support for microbusinesses selling pre owned goods. This move highlights Etsy's effort to influence policy around resale activity and align its marketplace with emerging circular economy priorities. Etsy runs a global marketplace...

Nutanix (NasdaqGS:NTNX) has partnered with San José Mineta International Airport to open The Nest by Nutanix, a sensory-friendly room for children with autism and sensory sensitivities. The dedicated space is now available to traveling families at SJC, offering a calmer environment before boarding. This initiative adds a community focused dimension to Nutanix’s profile, which is typically centered on its software and cloud offerings. Nutanix, trading at around $49.21 per share, has seen...

Astera Labs (NasdaqGS:ALAB) is scheduled to be added to the Nasdaq-100 Index in June 2026. This index inclusion marks a key milestone in the company’s public life and recognition within the AI infrastructure sector. The move may affect how global investors and index-tracking funds gain exposure to the stock. For investors tracking AI hardware, Astera Labs now sits alongside some of the largest US-listed companies through its upcoming addition to the Nasdaq-100 Index. The stock trades at...

CBRE Group (NYSE:CBRE) has promoted Jeremy Chism to managing director and market leader for Memphis and Jackson, Mississippi. The appointment places an experienced executive over key Southeast markets, with responsibilities across multiple property types. The move comes as CBRE is recognized for strong financial and operational performance and a solid outlook for growth. For you as an investor, this promotion speaks directly to how CBRE Group, a global commercial real estate services...

Nebius Group (NasdaqGS:NBIS) plans to invest approximately £1.7b in NVIDIA-powered AI infrastructure across three new UK sites. The company positions the UK as a key European hub for its AI data center capacity, aligned with the UK government's AI strategy. Nebius Group is set to join the Nasdaq-100 Index, increasing its visibility with global investors. Nebius Group focuses on AI infrastructure, supplying compute and data center capacity that can support businesses and public services...

At its recent DASH user conference, Datadog unveiled more than 100 new AI and security capabilities, including major enhancements to its Bits AI platform, AI Guard for protecting AI agents, and Bring Your Own Cloud to keep data processing within customers’ own environments. The event has prompted a wave of upbeat analyst commentary, with many viewing Datadog’s push toward autonomous observability and AI security as a meaningful expansion of its role in monitoring and controlling modern AI...

Investors may be wondering whether Thermo Fisher Scientific, at around US$475 per share, still offers value or if most of the opportunity is already priced in. The stock is up 14.9% over the past year, even though it is down 19.7% year to date and only slightly higher over the last month. This may have shifted how investors see its risk and reward trade off. Recent headlines have focused on Thermo Fisher Scientific's role across pharmaceuticals, biotech and lab tools. This keeps attention on...

Boise Cascade (BCC) recently reported Q1 2026 results showing a 2% revenue decline, as softer demand in its Building Materials Distribution and Wood Products segments met headwinds from adverse weather, geopolitical tensions, and volatile mortgage rates. See our latest analysis for Boise Cascade. The recent Q1 2026 update comes after a mixed period for the stock, with a 30 day share price return of 4.02% and a 1 year total shareholder return that declined 18.83%, signaling fading momentum...

Array Technologies recently announced an enhanced version of its OmniTrack terrain-following tracker, doubling post-to-post slope flexibility to 2°, which can reduce site grading, shorten piles, and lower construction and permitting complexity for utility-scale solar projects. The company also reported surpassing 100 GW of solar tracker deliveries across more than 30 countries, underscoring how its growing OmniTrack product line and domestic manufacturing focus are shaping its role in...

Virgin Galactic Holdings (NYSE:SPCE) has converted a portion of its debt into equity, which reduces future cash interest payments and extends debt maturities. The company has resolved governance related claims through a settlement that includes corporate reforms. These steps come as Virgin Galactic targets key flight tests in Q3 and the start of commercial operations in Q4 2026. For investors watching NYSE:SPCE, these balance sheet and governance changes arrive after a sharp move in the...

Luckin Coffee recently reported that, as of May 31, 2026, its freshly prepared tea and other non-coffee beverages generated over RMB 20.00 billion in cumulative sales, with 22 individual products each surpassing 100 million cups sold, while its global store network has expanded to more than 35,000 locations. This milestone underlines how Luckin Coffee is building a broad beverage platform beyond coffee, using non-coffee favorites and rapid store expansion to deepen its reach across China and...

Curtiss-Wright (CW) shares slipped after the company reported quarterly revenue 5.1% above analyst expectations, with 13.4% year on year growth, higher operating margins, and a 23% increase in adjusted diluted EPS. See our latest analysis for Curtiss-Wright. The earnings drop since the announcement comes after a strong recent run, with the share price up 32.3% year to date and a 1 year total shareholder return of 60%, pointing to positive but closely watched momentum around US$757 per...

If you are wondering whether Texas Instruments' current share price still offers value, it helps to step back and look at what the recent returns and valuation checks are really telling you. The stock closed at US$297.10, with the share price down 2.7% over the last 7 days, slightly up 0.7% over the last month, and showing returns of 67.4% year to date and 53.0% over the past year. Recent coverage has focused on the stock's multi year share price performance, with returns of 82.1% over 3...

Wondering whether Berkshire Hathaway stock still offers solid value at its current price, or if the best days are already priced in. The stock last closed at US$726,581, with a 1.1% gain over the past week, a slight 0.3% decline over the past month, and returns down 2.4% year to date and 1.1% over the past year, while the 3 and 5 year periods show total returns of 40.7% and 72.8%. Recent market attention has focused on Berkshire Hathaway's role as a diversified financial holding company and...